McNeill Jonathan Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
25
Insider Sells Sum
$5.63M

Insider Activity of McNeill Jonathan

According to the SEC Form 4 filings, McNeill Jonathan, being in a position of

  1. President and COO at Crescent Biopharma, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 25119 shares for $446,911,
    over all time since 2026-06-22, has bought 0 shares, and sold 25119 shares for $446,911.

Biography of McNeill Jonathan

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $446,9113100

Comparison of Insiders on Amount of Buys and Sells

2026-09-18SaleCrescent Biopharma, Inc.
CBIO
President and COO
3,839
0.0102%
$16.71$64,150-19.86%
2026-09-16SaleCrescent Biopharma, Inc.
CBIO
President and COO
731
0.0021%
$17.90$13,085-19.94%
2026-06-22SaleCrescent Biopharma, Inc.
CBIO
President and COO
20,549
0.0763%
$17.99$369,677-6.49%
2024-08-19SaleDyne Therapeutics, Inc.
DYN
Chief Business Officer
2,705
0.0039%
$45.12$122,054-69.88%
2024-06-11SaleDyne Therapeutics, Inc.
DYN
Chief Business Officer
1,823
0.0018%
$31.34$57,133-9.77%
2024-05-16SaleDyne Therapeutics, Inc.
DYN
Chief Business Officer
2,774
0.0025%
$28.27$78,420+2.23%
2024-03-11SaleDyne Therapeutics, Inc.
DYN
Chief Business Officer
19,601
0.016%
$25.50$499,842+15.11%
2024-03-08SaleDyne Therapeutics, Inc.
DYN
Chief Business Officer
90,000
0.0758%
$26.24$2.36M+17.01%
2024-03-07SaleDyne Therapeutics, Inc.
DYN
Chief Business Officer
2,434
0.002%
$25.85$62,919+11.23%
2024-03-01SaleDyne Therapeutics, Inc.
DYN
Chief Business Officer
24,260
0.0223%
$28.63$694,495+1.06%
2024-02-29SaleDyne Therapeutics, Inc.
DYN
Chief Business Officer
4,268
0.0038%
$27.50$117,370+9.33%
2024-01-26SaleDyne Therapeutics, Inc.
DYN
Chief Business Officer
20,000
0.0157%
$24.53$490,510+39.13%
2024-01-04SaleDyne Therapeutics, Inc.
DYN
Chief Business Officer
2,009
0.0012%
$18.04$36,242+51.52%
2024-01-03SaleDyne Therapeutics, Inc.
DYN
Chief Business Officer
17,991
0.0108%
$18.73$337,062+98.78%
2024-01-02SaleDyne Therapeutics, Inc.
DYN
Chief Business Officer
11,900
0.005%
$13.10$155,890+124.81%
2023-12-11SaleDyne Therapeutics, Inc.
DYN
Chief Business Officer
1,245
0.0004%
$10.72$13,346+169.36%
2023-09-18SaleDyne Therapeutics, Inc.
DYN
Chief Business Officer
1,261
0.0004%
$9.41$11,866+159.9%
2023-09-12SaleDyne Therapeutics, Inc.
DYN
Chief Business Officer
1,266
0.0004%
$10.41$13,179+156.31%
2023-06-13SaleDyne Therapeutics, Inc.
DYN
See Remarks
1,259
0.0005%
$12.43$15,649-7.46%
2023-06-12SaleDyne Therapeutics, Inc.
DYN
See Remarks
1,000
0.0004%
$13.00$13,000-4.87%
Total: 28
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.